Uranium chelating ability of decorporation agents in serum evaluated by X-ray absorption spectroscopy

X線吸収分光で評価した血清中ウランのキレート分離特性

上原 章寛*; 松村 大樹   ; 辻 卓也  ; 薬丸 晴子*; 田中 泉*; 城 鮎美*; 齋藤 寛之*; 石原 弘*; 武田(本間) 志乃*

Uehara, Akihiro*; Matsumura, Daiju; Tsuji, Takuya; Yakumaru, Haruko*; Tanaka, Izumi*; Shiro, Ayumi*; Saito, Hiroyuki*; Ishihara, Hiroshi*; Homma-Takeda, Shino*

Internal exposure to actinides such as uranium and plutonium has been reduced using chelating agents for decorporation because of their potential to induce both radiological and chemical toxicities. This study measures uranium chemical forms in serum in the presence and absence of chelating agents based on X-ray absorption spectroscopy (XAS). The chelating agents used were 1-hydroxyethane 1,1-bisphosphonate (EHBP), inositol hexaphosphate (IP6), deferoxamine B (DFO), and diethylenetriaminepentaacetate (DTPA). The main ligands forming complexes with uranium in the serum were estimated as follows: IP6 EHBP bioligands DFO DTPA when the concentration ratio of the chelating agent to uranium was 10. Measurements of uranium chemical forms and their concentrations in the serum would be useful for the appropriate treatment using chelating agents for the decorporation of uranium.